Penumbra, Inc. has grown revenue 17% a year over three years and 18% a year over five, with earnings per share compounding at 77%. Revenue growth, 3-year annual rate: +17% (Medical Devices median +12%). Revenue growth, 5-year rate: +18%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +77%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 13, FY2013 to FY2025, as filed.

PENPenumbra, Inc.

Healthcare

$319.42+25% 1Y

$319.42

$225.5452 weeks$359.40

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though revenue growing +18% year on year.

1 good, 2 neutral

Revenue trend+18% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +18% a year.

Earnings trend+8% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+0.0 points operating

Trailing-twelve-month operating margin, 12.5% now against 12.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 85% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PEN growing?

Penumbra, Inc. has grown revenue 17% a year over three years and 18% a year over five, with earnings per share compounding at 77%.

+17%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +18%
Revenue growth, 5-year rate · +17% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +77%
Earnings per share, 3-year rate · revenue +17% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed